Posted inComunicati
/C O R R E C T I O N — ARCOS/
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE In the news release, Arcos and OverIT Announce Integration and…
Posted inComunicati
Cadonix Launches smartBuild: An AI-First Manufacturing Solution that Modernizes Wire Harness Production
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE smartBuild debuts at the WHMA Annual Global Leadership Summit in…
Posted inComunicati
Pharyngeal Electrical Stimulation Recognized as Important Tool for Post-Stroke Recovery in New American Heart Association and American Stroke Association Guideline
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Inclusion in new Acute Ischemic Stroke guidelines underscores clinical utility…
Posted inComunicati
IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH KEPLER CHEUVREUX
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 27 January 2026 – Theon International…
Posted inComunicati
New indication in children from birth for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE VILLEPINTE, France, Jan. 27, 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT),…
Posted inComunicati
Arcos and OverIT Announce Integration and Distribution Partnership to Streamline Utility Field Operations
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE COLUMBUS, Ohio and MILAN, Jan. 27, 2026 /PRNewswire/ -- Arcos LLC,…
Posted inComunicati
Analytic Partners Recognized as a Leader by Multiple Independent Research Firms
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE MIAMI, Jan. 27, 2026 /PRNewswire/ -- Analytic Partners, the leader in…
Posted inComunicati
SNAI – Champions League: tutto in una notte. Napoli, vittoria qualificazione contro il Chelsea a 3,25
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Ultimi 90 minuti della fase campionato, con Atalanta, Inter…
Posted inComunicati
Kaspersky: in Italia quasi il 67% delle aziende sceglie di esternalizzare parte del proprio SOC
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Secondo una ricerca condotta da Kaspersky, la maggior parte delle…
Posted inComunicati
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Nine-month findings show mean improvement in Composite Unified Huntington's Disease…